X4 Pharmaceuticals
XFOR
XFOR
29 hedge funds and large institutions have $31.1M invested in X4 Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
19% less funds holding
Funds holding: 36 → 29 (-7)
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Holders
29
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$579K | |
| 2 | +$107K | |
| 3 | +$50.6K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$32.8K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$27.6K |
Top Sellers
| 1 | -$1M | |
| 2 | -$127K | |
| 3 | -$82K | |
| 4 |
Squarepoint
New York
|
-$81K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$64K |